MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Deals review

Deals of the day

Affymetrix Announces Major Genotyping Project With Kaiser Permanente and the University of California at San Francisco for NIH-Funded Epidemiology Study

SANTA CLARA, Calif.--Oct. 14, 2009-- Affymetrix, Inc. (Nasdaq:AFFX) today announced that the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the University of California at San Francisco (UCSF) have entered into an agreement with Affymetrix to support genome-wide analyses of DNA samples from 100,000 Kaiser Permanente members. more

Phase Forward and Merck Team Up to Win Society for Clinical Data Management Data Driven Innovation Award

WALTHAM, Mass.---Oct. 14, 2009-- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that a joint project with customer Merck & Co. has won the 2009 Society for Clinical Data Management (SCDM) Data Driven Innovation Award competition. This annual honor recognizes the year’s best advancement in clinical data management technology or service. more

Pressure BioSciences, Inc. and Protein Forest, Inc. Announce Collaborative Co- Marketing/Selling and R&D Agreement

South Easton, MA, October 14, 2009 – Pressure BioSciences, Inc. (NASDAQ: PBIO) (“PBI”) and Protein Forest, Inc. (“Protein Forest”), (together “the companies”), today announced that they have entered into a strategic co-marketing/selling and research & development agreement. The companies intend to co-market their respective product lines, including in industry publications, at scientific meetings, on each company’s website, through common collaborator studies, and at key industry trade shows.... more

Deals review search

Search the Pharmalicensing Deals Review by keyword. Alternatively, see all available reviews between any two dates.
 
Industrial sector Therapeutic target
Year

By month

November 2009 October 2009 September 2009 August 2009 July 2009 June 2009 May 2009 April 2009 March 2009 February 2009 January 2009 December 2008 November 2008 October 2008 September 2008 August 2008 July 2008 June 2008 May 2008 April 2008 March 2008 February 2008 January 2008 December 2007 November 2007

Search by date

Submit

More recent deals

PURE Bioscience Expands Business Strategy with Sales and Marketing Alliance for Long-Lasting, Broad Spectrum SDC Antimicrobial Products
San Diego, CA, Oct. 14, 2009 – PURE Bioscience (NASDAQ: PURE) announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont...

BioSante Pharmaceuticals and Cell Genesys Announce Completion of Merger
LINCOLNSHIRE, Ill. & SOUTH SAN FRANCISCO, Calif.--Oct. 14, 2009-- BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) and Cell Genesys, Inc. (NASDAQ:CEGE), today announced the successful completion of their...

Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University
TROY, Mich., Oct. 14, 2009-- Somanetics Corporation (Nasdaq: SMTS) today announced that it has signed an Exclusive Sublicense Agreement with Raba Equity Partners II, LLC ("Raba...

Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc
Mechelen, Belgium 14 October 2009 - Galapagos NV (Euronext: GLPG) announced today that it has expanded its global strategic alliance in metabolic diseases with an affiliate of Merck & Co., Inc to...

VAXIN LAUNCHES JOINT VENTURE WITH ANC BIO IN KOREA
Birmingham, Alabama – October 14, 2009 – Vaxin Inc., an emerging vaccine company today announced that it has entered into a joint venture with South Korean biomedical company, AnC Bio Group to...

GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
Issued: 13 October 2009, London, UK & Leiden, The Netherlands - GlaxoSmithKline (GSK) and Prosensa, the Dutch based biopharmaceutical company focusing on RNA modulating therapeutics, today announced...

KIMBERLY-CLARK ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE I-FLOW CORPORATION
DALLAS and LAKE FOREST, Calif., October 9, 2009 – Kimberly-Clark Corporation (NYSE: KMB) and I-Flow Corporation (NASDAQ: IFLO), a leading healthcare company that develops and markets technically...

MDS Announces Agreement to Sell Central Labs Operation to Czura Thornton
TORONTO, October 9, 2009 - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its...

SOLVAY AND HUATAI TO JOINTLY BUILD HYDROGEN PEROXIDE PLANT IN CHINA
October 9, 2009--Solvay today announces that it has struck an agreement with Huatai Group of China to establish a Hydrogen Peroxide joint venture. The joint venture company, Shandong Huatai Interox...

Ipsen acquires exclusive marketing rights of BLI-800 from Braintree for colonic cleansing before colonoscopy
Braintree (Massachusetts, United States) and Paris (France), 9 October 2009 – Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group and Braintree...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Pharmalicensing Jobs
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us